Honor — the technology-enabled home care startup that partners with independent agencies through the Honor Care Network — is gearing up for a major expansion. Those expansion plans are built around a substantial infusion of new capital, too. The San Francisco-based Honor announced Tuesday it… Read More »Honor Raises $140M to Fuel National Expansion
T. Rowe Price Associates
Kronos Bio raises $155M in private financing to advance lead leukemia drug into registration study next year
The company has raised $148 million so far and plans to raise the remaining $7 million by next month. Its lead candidate is entospletinib, a SYK inhibitor acquired as part of a deal with Gilead Sciences last month, under development for patients with biomarker-defined acute… Read More »Kronos Bio raises $155M in private financing to advance lead leukemia drug into registration study next year
The company is currently running a Phase I study of its lead candidate, the antibody-drug conjugate VLS-101, in patients with lymphomas and leukemias. It has two additional antibody-drug conjugates and a bispecific antibody in preclinical development.